Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315703325> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4315703325 endingPage "e44" @default.
- W4315703325 startingPage "e44" @default.
- W4315703325 abstract "Uric acid (UA) is the final product of purine metabolism and its increase in the circulating blood defines the presence of hyperuricaemia commonly considered as a concentration of uric acid in serum above the threshold level of 7 mg/dL (416 mol/L) in men and > 6 mg/dL in women. The typical consequence of elevated UA levels is the development of gout, a condition affecting 2–3% of the general population but beside the effects on gout, the elevated levels of UA have been associated with a significant increase in the risk of hypertension, metabolic syndrome, and cardiovascular disease (CVD) regardless of the presence of serum urate deposition. All this evidence clearly supports a primary cardiovascular role for elevated serum UA probably based on multiple and interactive mechanisms of action not necessarily involving the articular and tissue deposition. The interaction between elevated UA and cardiovascular diseases has been extensively investigated in the last 10 years providing interesting results in terms of patients identification, threshold of risk, pathophysiology, results of clinical trials and effects of drugs not primary involved in the management of uric acid levels. In particular, the evidence supports an increase of CV mortality and morbidity in patients with levels of SUA between 4.5 and 5.5 that are common in a large proportion of subjects and patients with overt cardiovascular diseases. This observation along with the differences in the mechanism leading to elevated UA (hyperproduction vs. underexcretion) will allow a more functional identification of patients suitable for pharmacological treatment with urate lowering drugs (ULT). Furthermore, the dynamic analysis of time-dependent trajectories of UA levels is a new approach to the interpretation and clinical management of cardiovascular disease. The overall representativity of a pattern of modification seems to better define the prognostic role of elevated UA and could be probably improved by an integrated interpretation of the different patterns beyond the role of risk cards and algorithms. Very recently, the management of elevated UA has also included the effects of non-ULT drugs as Losartan, SGLT-2 inhibitors, vericiguat whose administration in randomized clinical trials has improved uric acid levels with a linear proportion with the amount of UA reduction. The interaction between hyperuricemia and CVD is a very dynamic issue that has been recently enriched with several additional information that have allowed a more effective identification of those subsets of patients that can successfully treated in daily clinical practice" @default.
- W4315703325 created "2023-01-12" @default.
- W4315703325 creator A5055457360 @default.
- W4315703325 date "2023-01-01" @default.
- W4315703325 modified "2023-10-02" @default.
- W4315703325 title "S-17-1: URIC ACID AND CARDIOVASCULAR DISEASES" @default.
- W4315703325 doi "https://doi.org/10.1097/01.hjh.0000913132.99065.b3" @default.
- W4315703325 hasPublicationYear "2023" @default.
- W4315703325 type Work @default.
- W4315703325 citedByCount "0" @default.
- W4315703325 crossrefType "journal-article" @default.
- W4315703325 hasAuthorship W4315703325A5055457360 @default.
- W4315703325 hasBestOaLocation W43157033251 @default.
- W4315703325 hasConcept C10162356 @default.
- W4315703325 hasConcept C126322002 @default.
- W4315703325 hasConcept C134018914 @default.
- W4315703325 hasConcept C169586020 @default.
- W4315703325 hasConcept C181199279 @default.
- W4315703325 hasConcept C185592680 @default.
- W4315703325 hasConcept C2776476023 @default.
- W4315703325 hasConcept C2779134260 @default.
- W4315703325 hasConcept C2779721657 @default.
- W4315703325 hasConcept C2779881121 @default.
- W4315703325 hasConcept C2780402116 @default.
- W4315703325 hasConcept C2908647359 @default.
- W4315703325 hasConcept C42407357 @default.
- W4315703325 hasConcept C55493867 @default.
- W4315703325 hasConcept C71924100 @default.
- W4315703325 hasConcept C90924648 @default.
- W4315703325 hasConcept C99454951 @default.
- W4315703325 hasConceptScore W4315703325C10162356 @default.
- W4315703325 hasConceptScore W4315703325C126322002 @default.
- W4315703325 hasConceptScore W4315703325C134018914 @default.
- W4315703325 hasConceptScore W4315703325C169586020 @default.
- W4315703325 hasConceptScore W4315703325C181199279 @default.
- W4315703325 hasConceptScore W4315703325C185592680 @default.
- W4315703325 hasConceptScore W4315703325C2776476023 @default.
- W4315703325 hasConceptScore W4315703325C2779134260 @default.
- W4315703325 hasConceptScore W4315703325C2779721657 @default.
- W4315703325 hasConceptScore W4315703325C2779881121 @default.
- W4315703325 hasConceptScore W4315703325C2780402116 @default.
- W4315703325 hasConceptScore W4315703325C2908647359 @default.
- W4315703325 hasConceptScore W4315703325C42407357 @default.
- W4315703325 hasConceptScore W4315703325C55493867 @default.
- W4315703325 hasConceptScore W4315703325C71924100 @default.
- W4315703325 hasConceptScore W4315703325C90924648 @default.
- W4315703325 hasConceptScore W4315703325C99454951 @default.
- W4315703325 hasIssue "Suppl 1" @default.
- W4315703325 hasLocation W43157033251 @default.
- W4315703325 hasLocation W43157033252 @default.
- W4315703325 hasOpenAccess W4315703325 @default.
- W4315703325 hasPrimaryLocation W43157033251 @default.
- W4315703325 hasRelatedWork W1489127380 @default.
- W4315703325 hasRelatedWork W1983377204 @default.
- W4315703325 hasRelatedWork W2021507065 @default.
- W4315703325 hasRelatedWork W2255159497 @default.
- W4315703325 hasRelatedWork W2947097453 @default.
- W4315703325 hasRelatedWork W4243772414 @default.
- W4315703325 hasRelatedWork W4289653978 @default.
- W4315703325 hasRelatedWork W4386785473 @default.
- W4315703325 hasRelatedWork W860576688 @default.
- W4315703325 hasRelatedWork W2890068404 @default.
- W4315703325 hasVolume "41" @default.
- W4315703325 isParatext "false" @default.
- W4315703325 isRetracted "false" @default.
- W4315703325 workType "article" @default.